相关实验视频
Updated: Jan 16, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.3K
抗癌疗法诱导的心脏毒性:呼吁整合心脏瘤学实践
Giuliana Ciappina1, Luigi Colarusso2, Enrica Maiorana3
1Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
Pharmaceuticals (Basel, Switzerland)
|September 27, 2025
概括
新型癌症疗法改善了生存率,但增加了心血管毒性. 本文概述了一个框架,用于管理癌症幸存者的治疗相关心脏问题.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 新型癌症疗法,如向药物和免疫疗法,改善了生存率.
- 这些进步导致长期癌症幸存者的数量增加.
- 已经出现了以前未被识别的与治疗相关的毒性,特别是心血管不良事件的显著增加.
研究的目的:
- 综合当前关于与抗癌疗法相关的心脏毒性证据.
- 确定预防和管理癌症治疗诱导心脏毒性的关键知识差距.
- 倡导一个多学科的,基于证据的框架来管理心脏毒性.
主要方法:
- 文献综述和综合目前关于心脏毒性的证据.
- 分析与传统和新瘤疗法相关的心血管不良事件.
- 确定临床实践中的挑战和缺口.
主要成果:
- 心血管不良事件是癌症治疗的普遍和临床显著并发症.
- 心脏毒性可能会对心血管健康,治疗连续性和整体存活率产生负面影响.
- 现有的心脏毒性管理策略往往是不够的.
结论:
- 心脏毒性是现代癌症护理的一个主要问题,影响心血管健康和瘤治疗结果.
- 积极主动,多学科的方法对于管理心脏毒性至关重要.
- 实施基于证据的预防,早期检测和管理框架对于改善癌症幸存者的结果至关重要.
相关概念视频
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiomyopathy VI: Nursing Management
313
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
313
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cardiomyopathy II: Dilated Cardiomyopathy
470
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
470
Cardiomyopathy VII: Pre and Post Operative Nursing Management
287
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
287
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

